Gunn, N. T., Ling, L., Neff, G., Guy, C. D., Bashir, M., Frias, J. P., … Harrison, S. A. (2020). LIPID MANAGEMENT IN A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALDAFERMIN (NGM282). In HEPATOLOGY (Vol. 72, pp. 1022–1023).

Gunn, Nadege T., Lei Ling, Guy Neff, Cynthia D. Guy, Mustafa Bashir, Juan Pablo Frias, Ziad H. Younes, et al. “LIPID MANAGEMENT IN A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALDAFERMIN (NGM282).” In HEPATOLOGY, 72:1022–23, 2020.

Gunn NT, Ling L, Neff G, Guy CD, Bashir M, Frias JP, et al. LIPID MANAGEMENT IN A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALDAFERMIN (NGM282). In: HEPATOLOGY. 2020. p. 1022–3.

Gunn, Nadege T., et al. “LIPID MANAGEMENT IN A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALDAFERMIN (NGM282).” HEPATOLOGY, vol. 72, 2020, pp. 1022–23.

Gunn NT, Ling L, Neff G, Guy CD, Bashir M, Frias JP, Younes ZH, Trotter JF, Moussa S, Kohli A, Connelly MA, Nelson K, Gottwald M, Chang W, Yan AZ, DePaoli A, Lieu H, Harrison SA. LIPID MANAGEMENT IN A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALDAFERMIN (NGM282). HEPATOLOGY. 2020. p. 1022–1023.